These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 31299529)
1. Association of apolipoprotein E genotypes with epilepsy risk: A systematic review and meta-analysis. Liang Y; Zhou Z; Wang H; Cheng X; Zhong S; Zhao C Epilepsy Behav; 2019 Sep; 98(Pt A):27-35. PubMed ID: 31299529 [TBL] [Abstract][Full Text] [Related]
2. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis. Chen Q; Wang T; Kang D; Chen L Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759 [TBL] [Abstract][Full Text] [Related]
4. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis. Agarwal R; Tripathi CB Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132 [TBL] [Abstract][Full Text] [Related]
5. Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis. Jiang Y; He T; Deng W; Sun P Clin Interv Aging; 2017; 12():1941-1949. PubMed ID: 29180857 [TBL] [Abstract][Full Text] [Related]
6. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Lamar M; Yu L; Rubin LH; James BD; Barnes LL; Farfel JM; Gaiteri C; Buchman AS; Bennett DA; Schneider JA Alzheimers Dement; 2019 Feb; 15(2):258-266. PubMed ID: 30321502 [TBL] [Abstract][Full Text] [Related]
7. ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis. Shi J; Cheng Z; Qiu S; Cui H; Gu Y; Zhao Q; Ren Y; Zhang H; Sun H; Liu Y; Li Y; Qiao Y; Hu Y; Liu Y; Cheng Y Lipids Health Dis; 2020 Jun; 19(1):136. PubMed ID: 32534589 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients. Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY Gene; 2019 Oct; 715():144011. PubMed ID: 31357022 [TBL] [Abstract][Full Text] [Related]
9. Association of apolipoprotein E genotypes with lipid levels and coronary risk. Bennet AM; Di Angelantonio E; Ye Z; Wensley F; Dahlin A; Ahlbom A; Keavney B; Collins R; Wiman B; de Faire U; Danesh J JAMA; 2007 Sep; 298(11):1300-11. PubMed ID: 17878422 [TBL] [Abstract][Full Text] [Related]
10. APOE ε4 allele elevates the expressions of inflammatory factors and promotes Alzheimer's disease progression: A comparative study based on Han and She populations in the Wenzhou area. Fan YY; Cai QL; Gao ZY; Lin X; Huang Q; Tang W; Liu JH Brain Res Bull; 2017 Jun; 132():39-43. PubMed ID: 28461186 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals. Khan TA; Shah T; Prieto D; Zhang W; Price J; Fowkes GR; Cooper J; Talmud PJ; Humphries SE; Sundstrom J; Hubacek JA; Ebrahim S; Lawlor DA; Ben-Shlomo Y; Abdollahi MR; Slooter AJ; Szolnoki Z; Sandhu M; Wareham N; Frikke-Schmidt R; Tybjærg-Hansen A; Fillenbaum G; Heijmans BT; Katsuya T; Gromadzka G; Singleton A; Ferrucci L; Hardy J; Worrall B; Rich SS; Matarin M; Whittaker J; Gaunt TR; Whincup P; Morris R; Deanfield J; Donald A; Davey Smith G; Kivimaki M; Kumari M; Smeeth L; Khaw KT; Nalls M; Meschia J; Sun K; Hui R; Day I; Hingorani AD; Casas JP Int J Epidemiol; 2013 Apr; 42(2):475-92. PubMed ID: 23569189 [TBL] [Abstract][Full Text] [Related]
12. The association of apolipoprotein E (APOE) gene polymorphisms with atherosclerosis susceptibility: a meta-analysis. Zhu H; Xue H; Wang H; Ma Y; Liu J; Chen Y Minerva Cardioangiol; 2016 Feb; 64(1):47-54. PubMed ID: 26005211 [TBL] [Abstract][Full Text] [Related]
13. An updated meta-analysis: apolipoprotein E genotypes and risk of primary open-angle glaucoma. Liao R; Ye M; Xu X Mol Vis; 2014; 20():1025-36. PubMed ID: 25053873 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis. Neu SC; Pa J; Kukull W; Beekly D; Kuzma A; Gangadharan P; Wang LS; Romero K; Arneric SP; Redolfi A; Orlandi D; Frisoni GB; Au R; Devine S; Auerbach S; Espinosa A; Boada M; Ruiz A; Johnson SC; Koscik R; Wang JJ; Hsu WC; Chen YL; Toga AW JAMA Neurol; 2017 Oct; 74(10):1178-1189. PubMed ID: 28846757 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study. Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E gene polymorphism in the Mongolian population. Svobodová H; Kucera F; Stulc T; Vrablík M; Amartuvshin B; Altannavch Ts; Ceska R Folia Biol (Praha); 2007; 53(4):138-42. PubMed ID: 17706019 [TBL] [Abstract][Full Text] [Related]
17. A case-control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progression. De Feo E; Simone B; Persiani R; Cananzi F; Biondi A; Arzani D; Amore R; D'Ugo D; Ricciardi G; Boccia S BMC Cancer; 2012 Oct; 12():494. PubMed ID: 23098561 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis for the Association of Apolipoprotein E ε2/ε3/ε4 Polymorphism with Coronary Heart Disease. Zhang Y; Tang HQ; Peng WJ; Zhang BB; Liu M Chin Med J (Engl); 2015 May; 128(10):1391-8. PubMed ID: 25963363 [TBL] [Abstract][Full Text] [Related]
19. APOE Genotypes, Lipid Profiles, and Associated Clinical Markers in a Finnish Population with Cardiovascular Disease Risk Factors. Leskinen H; Tringham M; Karjalainen H; Iso-Touru T; Hietaranta-Luoma HL; Marnila P; Pihlava JM; Hurme T; Puolijoki H; Åkerman K; Mäkinen S; Sandell M; Vähäkangas K; Tahvonen R; Rokka S; Hopia A Lifestyle Genom; 2022; 15(2):45-54. PubMed ID: 34942620 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Bickeböller H; Campion D; Brice A; Amouyel P; Hannequin D; Didierjean O; Penet C; Martin C; Pérez-Tur J; Michon A; Dubois B; Ledoze F; Thomas-Anterion C; Pasquier F; Puel M; Demonet JF; Moreaud O; Babron MC; Meulien D; Guez D; Chartier-Harlin MC; Frebourg T; Agid Y; Martinez M; Clerget-Darpoux F Am J Hum Genet; 1997 Feb; 60(2):439-46. PubMed ID: 9012418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]